Prothena Corporation plc

NasdaqGS:PRTA 주식 보고서

시가총액: US$895.4m

Prothena 관리

관리 기준 확인 2/4

Prothena CEO는 Gene Kinney, Sep2016 에 임명되었습니다 의 임기는 8.17 년입니다. 총 연간 보상은 $ 7.04M, 9% 로 구성됩니다. 9% 급여 및 91% 보너스(회사 주식 및 옵션 포함). 는 $ 213.03K 가치에 해당하는 회사 주식의 0.024% 직접 소유합니다. 213.03K. 경영진과 이사회의 평균 재임 기간은 각각 7.7 년과 5.1 년입니다.

주요 정보

Gene Kinney

최고 경영자

US$7.0m

총 보상

CEO 급여 비율9.0%
CEO 임기8.2yrs
CEO 소유권0.02%
경영진 평균 재임 기간7.7yrs
이사회 평균 재임 기간5.1yrs

최근 관리 업데이트

Recent updates

Prothena: Delays And Data Uncertainty Undermine Case For Investing (Downgrade)

Oct 18

Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Oct 02
Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares

Jul 26
Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares

Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Jun 19
Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Prothena: Potential For Future Price Drop On Failure Risk Of Late-Stage Trials

Jun 07

New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)

May 14
New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)

Prothena: Alzheimer's Data Update In 2024 Could Move The Needle

Feb 23

Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%

Feb 08
Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%

Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?

Dec 20
Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?

Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business

Nov 24
Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business

Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk

Oct 27
Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk

Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Aug 25
Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today

May 10
What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today

We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Apr 23
We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook

Mar 01
Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook

We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate

Dec 28
We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate

Prothena: Paying A Premium To Cover All The Alzheimer's Bases

Sep 29

Prothena GAAP EPS of -$0.88 misses by $0.31

Aug 08

Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates

May 08
Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates

CEO 보상 분석

Gene Kinney 의 보수는 Prothena 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-US$51m

Mar 31 2024n/an/a

-US$172m

Dec 31 2023US$7mUS$631k

-US$147m

Sep 30 2023n/an/a

-US$73m

Jun 30 2023n/an/a

-US$141m

Mar 31 2023n/an/a

-US$128m

Dec 31 2022US$7mUS$601k

-US$117m

Sep 30 2022n/an/a

-US$156m

Jun 30 2022n/an/a

-US$1m

Mar 31 2022n/an/a

US$67m

Dec 31 2021US$5mUS$573k

US$67m

Sep 30 2021n/an/a

US$69m

Jun 30 2021n/an/a

-US$70m

Mar 31 2021n/an/a

-US$124m

Dec 31 2020US$3mUS$554k

-US$111m

Sep 30 2020n/an/a

-US$102m

Jun 30 2020n/an/a

-US$91m

Mar 31 2020n/an/a

-US$80m

Dec 31 2019US$3mUS$538k

-US$78m

Sep 30 2019n/an/a

-US$79m

Jun 30 2019n/an/a

-US$84m

Mar 31 2019n/an/a

-US$128m

Dec 31 2018US$11mUS$525k

-US$156m

Sep 30 2018n/an/a

-US$181m

Jun 30 2018n/an/a

-US$209m

Mar 31 2018n/an/a

-US$167m

Dec 31 2017US$5mUS$521k

-US$153m

보상 대 시장: Gene 의 총 보상 ($USD 7.04M )은 US 시장( $USD 3.23M ).

보상과 수익: 회사가 수익성이 없는 동안 Gene 의 보상이 증가했습니다.

CEO

Gene Kinney (55 yo)

8.2yrs

테뉴어

US$7,043,826

보상

Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...

리더십 팀

이름위치테뉴어보상소유권
Gene Kinney
President8.2yrsUS$7.04m0.024%
$ 213.0k
Tran Nguyen
CFO & Chief Strategy Officer11.7yrsUS$2.70m0.0060%
$ 53.3k
Brandon Smith
Chief Operating Officer3.1yrsUS$2.63m0%
$ 0
Carol Karp
Chief Regulatory Officer7.9yrsUS$2.57m0%
$ 0
Karin Walker
Chief Accounting Officer & Controller11.5yrs데이터 없음데이터 없음
Wagner Zago
Chief Scientific Officer7.4yrsUS$3.34m데이터 없음
Mark Johnson
Vice President of Investor Relationsno data데이터 없음데이터 없음
Michael Malecek
Chief Legal Officerno dataUS$1.18m데이터 없음
David Ford
Chief People Officerless than a year데이터 없음데이터 없음
Chad Swanson
Chief Development Officerless than a year데이터 없음데이터 없음
Yvonne Tchrakian
Company Secretaryno data데이터 없음데이터 없음

7.7yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: PRTA 의 관리팀은 노련하고 경험 (평균 재직 기간 7.7 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Gene Kinney
President8.2yrsUS$7.04m0.024%
$ 213.0k
Helen Kim
Independent Director2.3yrsUS$896.63k0%
$ 0
Richard Collier
Independent Director11.9yrsUS$912.48k0.0023%
$ 20.3k
Daniel Welch
Independent Chairmanless than a year데이터 없음데이터 없음
Lars Ekman
Independent Chair Emeritusless than a yearUS$923.48k0.00045%
$ 4.0k
Shane Cooke
Independent Director11.9yrsUS$917.26k0%
$ 0
Dennis Selkoe
Independent Director11.3yrsUS$901.73k0.0078%
$ 70.0k
Paula Cobb
Independent Director5.3yrsUS$908.48k0%
$ 0
Oleg Nodelman
Independent Director4.9yrs데이터 없음데이터 없음
William Dunn
Independent Director1.5yrsUS$1.70m데이터 없음

5.1yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: PRTA 의 이사회는 경험(평균 재직 기간 5.1 년)으로 간주됩니다.